How Digital Health and Real-World Evidence is Changing Clinical Trials

September 27, 2022

Although the traditional randomized controlled trial is the gold standard in research, the rise of digital health solutions is reshaping the field with the increased prevalence of alternative trial designs. These include decentralized digital clinical trials (DCT) that allow patients to enroll regardless of geographic constraints. This is made possible by the massive amount of real-world data (RWD) and real-world evidence (RWE) that digital health technology and electronic health records (EHR) provide.

According to MD+DI, “These trials collected many types of data including safety and efficacy data from trial participants from the commencement of the study to execution to follow-up. DCTs are able to capitalize on the advancements, and increased adoption of mobile technologies (cell phones, wearable watches, glasses, etc), connected devices (monitors, implantables, wearables, apps etc.,), and electronic patient engagement applications (ePROs), and social media platforms (WebMD, belong.life, PatientPoint, etc.,) to conduct the clinical trials from the comfort of the patient’s homes. This patient-centered transition increases the overall efficiency of clinical trials throughout the value chain – study design, site selection, recruitment, monitoring, data management, analysis, and reporting.”

To read more, click here.